TGF-β blockade using 1D11 only induced suppression of tumor growth when TGF-β blockade was initiated directly after tumor challenge (early intervention), and not when αTGF-β treatment was initiated when tumors were already established (late intervention). This evidence concerns the gene TGFB1 and neoplasm.